Table of Contents

company-logo

Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings. The company's ZTALMY product candidate acts at synaptic and extrasynaptic GABAA receptors, a target for its anti-seizure, antidepressant, and anxiolytic potential. It is developing ganaxolone for treating genetic epilepsy disorders, such as PCDH19-related epilepsy, tuberous sclerosis complex, depressive disorders, and Lennox-Gestaut Syndrome. Marinus Pharmaceuticals, Inc. has license agreement with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc.; and collaboration agreement with Orion Corporation. The company was incorporated in 2003 and is headquartered in Radnor, Pennsylvania.

Marinus Pharmaceuticals Dividend Announcement

• Marinus Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Marinus Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Marinus Pharmaceuticals Dividend History

Marinus Pharmaceuticals Dividend Yield

Marinus Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Marinus Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Marinus Pharmaceuticals Financial Ratios

P/E ratio-0.13
PEG ratio0.00
P/B ratio-0.28
ROE494.02%
Payout ratio0.00%
Current ratio1.66
Quick ratio1.47
Cash Ratio1.22

Marinus Pharmaceuticals Dividend FAQ

Does Marinus Pharmaceuticals stock pay dividends?
Marinus Pharmaceuticals does not currently pay dividends to its shareholders.
Has Marinus Pharmaceuticals ever paid a dividend?
No, Marinus Pharmaceuticals has no a history of paying dividends to its shareholders. Marinus Pharmaceuticals is not known for its dividend payments.
Why doesn't Marinus Pharmaceuticals pay dividends?
There are several potential reasons why Marinus Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Marinus Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Marinus Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Marinus Pharmaceuticals a dividend aristocrat?
Marinus Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Marinus Pharmaceuticals a dividend king?
Marinus Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Marinus Pharmaceuticals a dividend stock?
No, Marinus Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Marinus Pharmaceuticals stocks?
To buy Marinus Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Marinus Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.